Pricing Log in Create free account

ENDRA Life Sciences Inc. (NDRA) vs XWELL, Inc. (XWEL)

ENDRA Life Sciences Inc. and XWELL, Inc. are both Diagnostics & Research companies. ENDRA Life Sciences Inc. is the larger, with a market value of $7.5M against $6.1M — 1.2× the size. ENDRA Life Sciences Inc. has the higher net margin (0.00% vs −117.8%) and the lower return on invested capital (−539.9% vs 0.00%). Across the 15 metrics below, ENDRA Life Sciences Inc. leads on 9 and XWELL, Inc. on 6.

Valuation

Metric NDRA XWEL Diagnostics & Research median
P/E n/m n/m 34.52
P/S 17.21 0.17 4.24
P/B 0.98 0.59 3.42
Price to free cash flow n/m n/m 33.51
EV/EBITDA n/m 0.12 23.44
EV/Sales 1.88 (0.06) 5.18
Earnings yield (127.31%) (933.33%) (1.50%)
Free cash flow yield (127.37%) (278.57%) 0.00%

Profitability

Metric NDRA XWEL Diagnostics & Research median
Gross margin 0.00% 34.34% 48.32%
Operating margin 0.00% (61.31%) (5.68%)
Net margin 0.00% (117.83%) (4.10%)
Free cash flow margin 0.00% (47.65%) 0.00%
Return on equity (152.04%) (557.21%) 0.00%
Return on assets (110.08%) (155.10%) (6.05%)
Return on invested capital (539.89%) 0.00% 0.00%

Growth

Metric NDRA XWEL Diagnostics & Research median
Revenue growth (TTM) — (7.58%) 8.99%
EPS growth (last fiscal year) 84.32% (38.80%) 20.36%
Revenue growth, 5-year CAGR — 28.35% 7.30%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NDRA XWEL Diagnostics & Research median
Debt to equity 0.00 0.00 0.01
Current ratio 7.10 2.27 2.27
Net debt to EBITDA 0.14 (0.08) 0.68

Dividend

Metric NDRA XWEL Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric NDRA XWEL Diagnostics & Research median
Market cap 7.51m 6.08m 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack